Osteoarthritis is the most common joint disease : it affects nearly 10 million people in France and 65% of those over 65.
Beyond the cartilage, this condition also affects the bone just beneath it and the synovial membrane, which lines the inside of the joint. What causes it? Aging, heredity, metabolic abnormalities, and certain diseases.
Its management remains primarily symptomatic. Pain is relieved, but we still do not know how to slow the progression of the disease.
While doing my scientific watch, I came across a lead that you don’t necessarily think of when talking about joints: the gut.
The hypothesis is as follows. An imbalanced microbiota would make the intestinal wall more permeable and allow fragments of bacteria to pass into the bloodstream, sustaining low-grade inflammation, even in the joints.
It remains to be seen whether acting on the microbiota truly relieves patients. That is what Tao Li, from the rheumatology department of the affiliated hospital of Jiangxi University of Chinese Medicine (China), and his team wanted to verify. Together, let’s decode this meta-analysis published in September 2026.
📚 Read also | We analyzed 14 probiotic brands in detail
How did the researchers proceed?
To answer this question, the researchers compiled 18 randomized clinical trials, conducted in 13 countries between 2010 and 2025. In total, just over 2,000 participants, aged on average between 55 and 70 and most often suffering from knee osteoarthritis: a substantial sample on paper.
To act on the microbiota, the trials relied on several approaches:
- probiotics, in 8 trials. The strains varied widely from one study to another: Lactobacillus casei Shirota, Saccharomyces boulardii, Latilactobacillus sakei, Streptococcus thermophilus, Bifidobacterium lactis, or even a mix of 8 strains
- dietary changes, in 8 other trials: Mediterranean diet, plant-based diet, or very low-calorie diets
- prebiotics, in 1 trial: fibers that feed good bacteria
- symbiotics, in 1 trial: the combination of a probiotic and a prebiotic
According to the studies, participants followed the intervention for 6 weeks to 4 years.
To assess effectiveness, the researchers looked at:
- pain, stiffness, and joint function, assessed in particular with the WOMAC score, a reference questionnaire for knee and hip osteoarthritis
- several markers of inflammation in the blood
- a marker of cartilage degradation, COMP
What do the results show?
Less pain and an easier daily life
For each criterion, the researchers assessed the level of certainty of the evidence, from very low to high.
In 8 of the trials, participants rated their pain using the WOMAC questionnaire. By pooling these results, the researchers observed that those who had received a probiotic or followed a diet reported, on average, less pain than the control groups (placebo, usual diet, or another diet). The difference appears moderate, with a moderate level of certainty as well.
The same questionnaire also assesses joint function, that is, how easy it is to perform everyday activities. In fact, this is the result I prioritize: the improvement there is more modest, but it is the only one rated with high certainty.
Stiffness, however, did not decrease significantly.
An inflammation that decreases
Three inflammatory markers decrease in the blood:
- CRP, produced by the liver in response to inflammation
- sedimentation rate, another classic indicator of inflammation
- interleukin-1 beta, a molecule that activates the enzymes responsible for breaking down cartilage
The authors put forward a hypothesis: some gut bacteria may produce more butyrate, a fatty acid with anti-inflammatory effects, but this mechanism was not measured in this meta-analysis.
In osteoarthritis, inflammatory molecules make the joint nerves more reactive, and the pain more intense. Reducing inflammation could therefore also help relieve pain.
And what about cartilage?
This is a point I want to emphasize: COMP, a protein released into the blood when cartilage breaks down, remained stable in the 3 trials that measured it.
So there is nothing to suggest that these approaches protect cartilage or slow the disease: they may help people live better with osteoarthritis, not make it go away.
Probiotics or diet: which works better?
For pain, probiotics seem more effective than dietary changes, but the difference is not quite significant. And since each strain was tested in only one or two trials, I would not go so far, at this stage, as to recommend one strain over another.
My view as a pharmacist
The gut-joint axis appears to be a serious lead: the meta-analysis shows effects on pain, joint function, and inflammation.
I remain cautious, however: the trials included are very heterogeneous. Strains, doses, durations, patient profiles: everything varies enormously from one study to another.
By the way, the effect likely does not come solely through the microbiota. Several trials relied on very low-calorie diets, so on weight loss. Yet fewer pounds also means less pressure on the knee, and therefore potentially less pain.
The authors themselves also speak of preliminary conclusions. These results still need to be confirmed, and I think new standardized trials would be necessary.
Above all, I want to remind you that probiotics are not a treatment for osteoarthritis. If you want to try them, I recommend that you choose an identified strain that has already been tested in osteoarthritis, such as Lactobacillus casei Shirota or Saccharomyces boulardii, and discuss it with your doctor or pharmacist.
Sources and scientific studies
Li T, Long J, Zhang Y, Luo H, Yu J. (2026) Effects of gut microbiota-targeted interventions on pain, physical function, and inflammatory biomarkers in osteoarthritis: a systematic review and meta-analysis of randomized controlled trials. https://doi.org/10.3389/fcimb.2026.1907672


